Posit Science's BrainHQ Cognitive Training Cuts Alzheimer’s Risk by 25% in Landmark Study
Event summary
- NIH-funded ACTIVE Study found Posit Science’s BrainHQ speed training reduced Alzheimer’s/dementia diagnoses by 25% over 20 years in 2,800+ participants.
- Speed training was the only intervention among four tested (memory, reasoning, control) to show significant long-term benefits.
- Total training time was less than 23 hours over three years, with booster sessions critical to sustained results.
- Study published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (Feb. 2026).
The big picture
This study validates cognitive training as a viable Alzheimer’s prevention tool, contrasting with expensive drugs that only slow decline. Posit Science now holds exclusive rights to the only intervention proven to reduce dementia incidence in Medicare data. The results could reshape preventive healthcare strategies for aging populations, with implications for both public health policy and the digital therapeutics market.
What we're watching
- Commercialization Potential
- Whether BrainHQ can scale adoption among health plans, medical centers, and aging populations following these results.
- Competitive Differentiation
- How Posit Science will position speed training against other cognitive interventions lacking similar evidence.
- Regulatory & Reimbursement
- The pace at which payers recognize BrainHQ as a preventative healthcare tool, given its long-term cost-saving implications.
Related topics